母胎医学杂志（英文）（Maternal-Fetal Medicine杂志栏目及论文类型发文方向
/有基金 100.0%
母胎医学杂志（英文）（Maternal-Fetal Medicine杂志征稿要求
1、投稿方式：在线投稿。
2、刊内网址：
http://www.maternal-fetalmedicine.org（202302期）
自动跳转至：
https://journals.lww.com/mfm/pages/default.aspx
3、投稿系统：
https://www.editorialmanager.com/mfm/default.aspx
4、中华医学会期刊主页：
https://mednexus.org/journal/mfm
（从中华医学期刊网https://www.medjournals.cn进入）
5、出刊日期：季刊，逢季首月25日出版。
2023年7月28日星期五
《母胎医学杂志（英文）》投稿须知
【官网信息】
投稿须知：https://edmgr.ovid.com/mfm/accounts/ifauth.htm
INSTRUCTIONS FOR AUTHORS
The
Editorial Office is pleased to answer any questions you may have about
preparing your manuscript in accordance with the guidelines.
E-mail: mfm@cmaph.org, mfmedicine@126.com
AIMS AND SCOPE
Maternal-Fetal
Medicine (MFM) is a newly launched international peer-reviewed journal
of the Chinese Medical Association. The aim of the journal is to publish
high quality scientific articles in all areas of Obstetrics and
Maternal-Fetal Medicine, including original clinical and translational
research, state-of-the-art reviews, commentaries, case studies and case
reports, and letters to the editor. Articles are published quarterly.
The journal is available both in print and online.
Areas covered include but not limited to:
Medical complications of pregnancy
Adverse events of pregnancy
Fetal development
Prenatal screening and diagnosis
Fetal Treatment and Therapy
Technology and developments in the field of Obstetrics and Maternal-Fetal Medicine
ONLINE SUBMISSION
All manuscripts must be submitted online through the website:
https://www.editorialmanager.com/mfm
First-time
users will have to register at this site. Registration is free but
mandatory. Registered authors can keep track of their articles after
logging into the site using their username and password. Authors do not
have to pay for submission of articles. If you experience any problems,
please contact the editorial office by E-mail: mfm@cmaph.org;
mfmedicine@126.com.
JOURNAL POLICIES
DUPLICATE PUBLICATION
Manuscripts
are reviewed for possible publication with the understanding that they
are being submitted only to MFM and have not been published,
simultaneously submitted, or already accepted for publication elsewhere.
The Editorial team may subject any manuscript submitted for
consideration of publication in MFM to plagiarism-detection software.
This
does not preclude consideration of a manuscript that has been rejected
by another journal or a complete report that follows publication of
preliminary findings elsewhere, usually in the form of an abstract.
Copies of any possibly duplicate published material should be submitted
with the manuscript under consideration, with a statement in the cover
letter as to why the manuscript currently being submitted is not a
duplicate publication.
DISCLOSURE OF CONFLICTS
Authors
must state all possible conflicts of interest in the manuscript,
including financial, consultant, institutional and other relationships
that might lead to bias or a conflict of interest. If there is no
conflict of interest, this should also be explicitly stated as none
declared. All sources of funding should be acknowledged in the
manuscript. All relevant conflicts of interest and sources of funding
should be included on the title page of the manuscript with the heading
"Conflicts of Interest and Source of Funding:" For example: “Conflicts
of Interest and Source of Funding: A has received honoraria from Company
Z. B is currently receiving a grant (#12345) from Organization Y, and
is on the speaker's bureau for Organization X - the CME organizers for
Company A. For the remaining authors, no relevant conflicts of interest
were declared.”
Financial Support and Competing Interests
A
financial disclosure section is part of the submission process and must
be completed by each author at submission. This information is for
review by the Editors but will be published if relevant to the content
of the accepted manuscript.
The
primary purpose of the disclosure section is to determine whether
authors have received any commercial financial support that could create
a conflict of interest. In addition to monetary interests, a potential
for conflict of interest can exist whether or not an individual believes
that a relationship (such as dual commitments, competing interests, or
competing loyalties) affects his or her scientific judgment. Please
review ICMJE Uniform Requirements for Manuscripts.
AUTHORSHIP
MFM
expects that each person listed as an author has participated
sufficiently in the intellectual content, the analysis of data, and/or
the writing of the manuscript to take public responsibility for it. Each
author must have reviewed the manuscript, believes it represents valid
work, and approves it for submission.
Moreover,
should the Editorial team request the data upon which the manuscript is
based, the authors shall provide the data. Each author’s specific
contributions to the work should be indicated; this information will be
published as a footnote to the paper. For example, the areas of
participation might include:
Participated in research design
Participated in the writing of the paper
Participated in the performance of the research
Contributed new reagents or analytic tools
Participated in data analysis
An
author may list more than one contribution, and more than one author
may have contributed to the same aspect of the work. Any change in
authorship/contributions after submission must be approved in writing by
all authors and submitted to the Editorial Office for final
consideration.
RETRACTION POLICY
MFM should consider retracting a publication if:
Editors
have clear evidence that the findings are unreliable, either as a
result of misconduct (e.g., data fabrication) or honest error (e.g.,
miscalculation or experimental error).
The
findings have previously been published elsewhere without proper
crossreferencing, permission or justification (i.e., cases of redundant
publication).
It constitutes plagiarism.
It reports unethical research.
MFM
abides by Retraction Guidelines of the Committee on Publication Ethics
(COPE)
(http://publicationethics.org/files/retraction%20guidelines_0.pdf).
等等……
